Advances in Hematological Malignancies
Recent years have witnessed remarkable progress in the area of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and gene editing are transforming the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering hope for more effective treatment o